Showing results (1491-1500 of 1,655) with videos related to

Sort By:
Pageof 166
Vascular Medicine (London, England)|July 12, 2018
Ticagrelor versus clopidogrel in patients with symptomatic peripheral artery disease and prior coronary artery disease: Insights from the EUCLID trialJeffrey S Berger, Beth L Abramson, Renato D Lopes, et al.
Heart & Lung : the Journal of Critical Care|November 5, 2022
Sex differences in the prognostic value of troponin and D-dimer in COVID-19 illnessAmrita Mukhopadhyay, Nina Talmor, Yuhe Xia, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 4, 2001
Efficacy and safety of gemtuzumab ozogamicin in patients with CD33-positive acute myeloid leukemia in first relapseE L Sievers, R A Larson, E A Stadtmauer, et al.
Journal of the American Heart Association|April 26, 2022
Platelet Function Is Associated With Dementia Risk in the Framingham Heart StudyJaime Ramos-Cejudo, Andrew D Johnson, Alexa Beiser, et al.
Journal of Neuro-Oncology|October 24, 2015
Clinical outcome and prognostic factors for central neurocytoma: twenty year institutional experienceBrandon S Imber, Steve E Braunstein, Fred Y Wu, et al.
Nature Cardiovascular Research|November 29, 2024
Immune checkpoint landscape of human atherosclerosis and influence of cardiometabolic factorsJosé Gabriel Barcia Durán, Dayasagar Das, Michael Gildea, et al.
Cancers|July 13, 2024
Deconstructing Intratumoral Heterogeneity through Multiomic and Multiscale Analysis of Serial SectionsPatrick G Schupp, Samuel J Shelton, Daniel J Brody, et al.
Biorxiv : the Preprint Server for Biology|August 30, 2023
Deconstructing intratumoral heterogeneity through multiomic and multiscale analysis of serial sectionsPatrick G Schupp, Samuel J Shelton, Daniel J Brody, et al.
Cell Reports|March 29, 2018
Comprehensive Molecular Profiling Identifies FOXM1 as a Key Transcription Factor for Meningioma ProliferationHarish N Vasudevan, Steve E Braunstein, Joanna J Phillips, et al.
Neurosurgery|January 4, 2022
Association of Neurological Impairment on the Relative Benefit of Maximal Extent of Resection in Chemoradiation-Treated Newly Diagnosed Isocitrate Dehydrogenase Wild-Type GlioblastomaAlexander A Aabedi, Jacob S Young, Yalan Zhang, et al.
Pageof 166